Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 7035025, 13 pages
https://doi.org/10.1155/2017/7035025
Clinical Study

The Efficacy of Single-Dose versus Double-Dose Praziquantel Treatments on Schistosoma mansoni Infections: Its Implication on Undernutrition and Anaemia among Primary Schoolchildren in Two On-Shore Communities, Northwestern Tanzania

1Department of Global Health and Bio-Medical Sciences, School of Life Sciences and Bio-Engineering, Nelson Mandela African Institution of Science and Technology (NM-AIST), P.O. Box 447, Arusha, Tanzania
2Department of Bio-Medical Sciences, School of Medicine and Dentistry, College of Health Sciences, University of Dodoma, P.O. Box 259, Dodoma, Tanzania
3National Institute for Medical Research (NIMR), Mwanza Research Centre, Isamilo Road, P.O. Box 1462, Mwanza, Tanzania

Correspondence should be addressed to David Z. Munisi; zt.ca.tsia-mn@disinum

Received 24 April 2017; Revised 8 August 2017; Accepted 21 August 2017; Published 28 September 2017

Academic Editor: Mingtao Zeng

Copyright © 2017 David Z. Munisi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. H. Molyneux, P. J. Hotez, and A. Fenwick, “‘Rapid-impact interventions’: how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor,” PLoS Medicine, vol. 2, no. 11, article no. e336, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Gryseels, K. Polman, J. Clerinx, and L. Kestens, “Human schistosomiasis,” The Lancet, vol. 368, no. 9541, pp. 1106–1118, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Steinmann, J. Keiser, R. Bos, M. Tanner, and J. Utzinger, “Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk,” Lancet Infectious Diseases, vol. 6, no. 7, pp. 411–425, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. C. H. King, “Parasites and poverty: the case of schistosomiasis,” Acta Tropica, vol. 113, no. 2, pp. 95–104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. WHO, Prevention and control of schistosomiasis and soil-transmittedhelminthiasis: report of a WHO expert committee, 2002.
  6. B. J. Vennervald, L. Kenty, A. E. Butterworth et al., “Detailed clinical and ultrasound examination of children and adolescents in a Schistosoma mansoni endemic area in Kenya: hepatosplenic disease in the absence of portal fibrosis,” Tropical Medicine & International Health, vol. 9, no. 4, pp. 461–470, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. J. Van Der Werf, S. J. De Vlas, S. Brooker et al., “Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa,” Acta Tropica, vol. 86, no. 2-3, pp. 125–139, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Harrison, “Schistosomiasis and other trematode infection,” Harrrisons Principles of Internal Medicine, pp. 1266–1271, 2005. View at Google Scholar
  9. H. D. Mazigo, F. Nuwaha, S. M. Kinung'hi et al., “Epidemiology and control of human schistosomiasis in Tanzania,” Parasites and Vectors, vol. 5, no. 1, article 274, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Rollinson, S. Knopp, S. Levitz et al., “Time to set the agenda for schistosomiasis elimination,” Acta Tropica, vol. 128, no. 2, pp. 423–440, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. F. McCullough, “The distribution of Schistosoma mansoni and S. haematobium in East Africa,” Tropical and Geographical Medicine, vol. 24, pp. 199–207, 1972. View at Google Scholar
  12. D. Z. Munisi, J. Buza, E. A. Mpolya, and S. M. Kinung'hi, “Intestinal schistosomiasis among primary schoolchildren in two on-shore communities in rorya district, northwestern tanzania: prevalence, intensity of infection and associated risk factors,” Journal of Parasitology Research, vol. 2016, Article ID 1859737, 11 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. S. M. Kinung'hi, P. Magnussen, G. M. Kaatano, C. Kishamawe, and B. J. Vennervald, “Malaria and helminth co-infections in school and preschool children: a cross-sectional study in Magu district, North-Western Tanzania,” PLoS ONE, vol. 9, no. 1, Article ID e86510, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. S. M. Kinung'hi, P. Magnussen, C. Kishamawe, J. Todd, and B. J. Vennervald, “The impact of anthelmintic treatment intervention on malaria infection and anaemia in school and preschool children in Magu district, Tanzania: an open label randomised intervention trial,” BMC Infectious Diseases, vol. 15, no. 1, article no. 136, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. H. D. Mazigo, D. W. Dunne, D. Morona et al., “Periportal fibrosis, liver and spleen sizes among S. mansoni mono or co-infected individuals with human immunodeficiency virus-1 in fishing villages along Lake Victoria shores, North-Western, Tanzania,” Parasites and Vectors, vol. 8, article no. 260, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Mekonnen, M. Legesse, M. Belay et al., “Efficacy of Praziquantel against Schistosoma haematobium in Dulshatalo village, western Ethiopia,” BMC Research Notes, vol. 6, no. 1, article no. 392, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. WHO, Preventive Chemotherapy in Human Helminthiasis: Coordinated Use of Anthelmintic Drugs in Control Interventions: A Manual for Health Professionals and Programme Managers, World Health Organization, Geneva, Switzerland, 2006.
  18. L. Savioli, A. F. Gabrielli, A. Montresor, L. Chitsulo, and D. Engels, “Schistosomiasis control in Africa: 8 years after World Health Assembly Resolution 54·19,” Parasitology, vol. 136, no. 13, pp. 1677–1681, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. G. Chipeta, B. Ngwira, and L. N. Kazembe, “Analysis of schistosomiasis haematobium infection prevalence and intensity in Chikhwawa, Malawi: an application of a two part model,” PLoS Neglected Tropical Diseases, vol. 7, no. 3, article e2131, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. D. G. Colley, A. L. Bustinduy, W. E. Secor, and C. H. King, “Human schistosomiasis,” The Lancet, vol. 383, pp. 2253–2264, 2014. View at Publisher · View at Google Scholar
  21. UN Sustainable Development Goals, “Goal 3: Ensure healthy lives and promote well-being for all at all ages”.
  22. A. A. Sabah, C. Fletcher, G. Webbe, and M. J. Doenhoff, “Schistosoma mansoni: Chemotherapy of infections of different ages,” Experimental Parasitology, vol. 61, no. 3, pp. 294–303, 1986. View at Publisher · View at Google Scholar · View at Scopus
  23. M. J. Doenhoff, D. Cioli, and J. Utzinger, “Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis,” Current Opinion in Infectious Diseases, vol. 21, no. 6, pp. 659–667, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Utzinger, J. Keiser, X. Shuhua, M. Tanner, and B. H. Singer, “Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials,” Antimicrobial Agents and Chemotherapy, vol. 47, no. 5, pp. 1487–1495, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Garba, M. S. Lamine, N. Barkiré et al., “Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger,” Acta Tropica, vol. 128, no. 2, pp. 334–344, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Jordan, “From Katayama to the Dakhla Oasis: the beginning of epidemiology and control of bilharzia,” Acta Tropica, vol. 77, no. 1, pp. 9–40, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. C. O. Obonyo, E. M. Muok, and P. N. Mwinzi, “Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: an open-label randomised controlled trial,” The Lancet Infectious Diseases, vol. 10, no. 9, pp. 603–611, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. M. J. Doenhoff, P. Hagan, D. Cioli et al., “Praziquantel: its use in control of schistosomiasis in sub-saharan africa and current research needs,” Parasitology, vol. 136, no. 13, pp. 1825–1835, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. M. S. Wolfe, “Schistosoma mansoni infection: Failure of standard treatment with praziquantel in a returned traveller,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 97, no. 6,1, 720 pages, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. A. J. Norton, C. M. Gower, P. H. L. Lamberton et al., “Genetic consequences of mass human chemotherapy for Schistosoma mansoni: population structure pre- and post-praziquantel treatment in Tanzania,” American Journal of Tropical Medicine and Hygiene, vol. 83, no. 4, pp. 951–957, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. B. L. Webster, O. T. Diaw, M. M. Seye et al., “Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns,” Acta Tropica, vol. 128, no. 2, pp. 292–302, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Utzinger, E. K. N'Goran, C. R. Caffrey, and J. Keiser, “From innovation to application: social-ecological context, diagnostics, drugs and integrated control of schistosomiasis,” Acta Tropica, vol. 120, supplement 1, pp. S121–S137, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. G. C. Webber and B. Chirangi, “Women's health in women's hands: a pilot study assessing the feasibility of providing women with medications to reduce postpartum hemorrhage and sepsis in rural Tanzania,” Health Care for Women International, vol. 35, no. 7–9, pp. 758–770, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Z. Munisi, J. Buza, E. A. Mpolya, and S. M. Kinung'hi, “Schistosoma mansoni infections, undernutrition and anaemia among primary schoolchildren in two onshore villages in Rorya District, North-Western Tanzania,” PLoS ONE, vol. 11, no. 12, Article ID e0167122, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Kirkwood, Essential Medical Statistics, Blackwell Science Ltd, Massachusetts, USA, 2003, pp. 413-427.
  36. N. B. Kabatereine, J. Kemijumbi, J. H. Ouma et al., “Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, Uganda,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 97, no. 5, pp. 599–603, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Katz, A. Chaves, and J. Pellegrino, “A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni,” in Revista do Instituto de Medicina Tropical de São Paulo, vol. 14, article 397, 1972. View at Google Scholar
  38. WHO, Basic Laboratory Methods in Medical Parasitology, World Health Organisation, Geneva, Switzerland, 1991.
  39. WHO, WHO Anthroplus Software, Software for Assessing Growth and Development of the World’S Children, WHO, Geneva, Switzerland, 2007.
  40. K. Bailey and A. Ferro-Luzzi, “Use of body mass index of adults in assessing individual and community nutritional status,” Bulletin of the World Health Organization, vol. 73, article 673, 1995. View at Google Scholar
  41. H. Von Schenck, M. Falkensson, and B. Lundberg, “Evaluation of ‘HemoCue,' a new device for determining hemoglobin,” Clinical Chemistry, vol. 32, pp. 526–529, 1986. View at Google Scholar
  42. WHO, Iron Deficiency Anaemia: Assessment, Prevention, and Control: A Guide for Programme Managers, World Health Organization, Geneva, Switzerland, 2001.
  43. E. M. Tukahebwa, B. J. Vennervald, F. Nuwaha, N. B. Kabatereine, and P. Magnussen, “Comparative efficacy of one versus two doses of praziquantel on cure rate of Schistosoma mansoni infection and re-infection in Mayuge District, Uganda,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 107, no. 6, pp. 397–404, 2013, trt024. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Raso, E. K. N'Goran, A. Toty et al., “Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 98, no. 1, pp. 18–27, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Sacko, P. Magnussen, M. Traorŕ et al., “The effect of single dose versus two doses of praziquantel on Schistosoma haematobium infection and pathology among school-aged children in Mali,” Parasitology, vol. 136, no. 13, pp. 1851–1857, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Utzinger, E. K. N'goran, A. N'dri, C. Lengeler, and M. Tanner, “Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection,” Tropical Medicine and International Health, vol. 5, no. 11, pp. 771–778, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. B. Gryseels, L. Nkulikyinka, and M. H. Coosemans, “Field trials of praziquantel and oxamniquine for the treatment of schistosomiasis mansoni in Burundi,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 81, no. 4, pp. 641–644, 1987. View at Publisher · View at Google Scholar · View at Scopus
  48. C. L. Black, M. L. Steinauer, P. N. M. Mwinzi, W. Evan Secor, D. M. S. Karanja, and D. G. Colley, “Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya,” Tropical Medicine and International Health, vol. 14, no. 4, pp. 450–457, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. A. A. Daffalla and A. Fenwick, “Resurgence of Schistosoma mansoni and Schistosoma haematobium after the end of a 4-year control programme against S. mansoni,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 76, no. 5, pp. 701-702, 1982. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Ernould, A. Garba, R. Labbo, AK. Kaman, A. Sidiki et al., “Heterogeneity of Schistosoma haematobium transmission in irrigated fields,” Bulletin de la Societe de pathologie exotique, vol. 97, no. 1990, pp. 19–23, 2004. View at Google Scholar
  51. E. K. N'Goran, J. Utzinger, A. N. N'Guessan et al., “Reinfection with Schistosoma haematobium following school‐based chemotherapy with praziquantel in four highly endemic villages in Côte d’Ivoir,” Tropical Medicine and International Health, vol. 6, no. 10, pp. 817–825, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. A. I. Kahama, B. J. Vennervald, Y. Kombe et al., “Parameters associated with Schistosoma haematobium infection before and after chemotherapy in school children from two villages in the Coast province of Kenya,” Tropical Medicine and International Health, vol. 4, no. 5, pp. 335–340, 1999. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Leenstra, S. K. Kariuki, J. D. Kurtis, A. J. Oloo, P. A. Kager, and F. O. ter Kuile, “Prevalence and severity of anemia and iron deficiency: cross-sectional studies in adolescent schoolgirls in western Kenya,” European Journal of Clinical Nutrition, vol. 58, no. 4, pp. 681–691, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. A. M. Assis, M. L. Barreto, M. S. Prado, M. G. Reis, I. M. Parraga et al., “Schistosoma mansoni infection and nutritional status in schoolchildren: a randomized, double-blind trial in northeastern Brazil,” The American journal of clinical nutrition, vol. 68, pp. 1247–1253, 1998. View at Google Scholar
  55. A. M. O. Assis, M. S. Prado, M. L. Barreto et al., “Childhood stunting in Northeast Brazil: the role of Schistosoma mansoni infection and inadequate dietary intake,” European Journal of Clinical Nutrition, vol. 58, pp. 1022–1029, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Koukounari, A. Fenwick, S. Whawell et al., “Morbidity indicators of Schistosoma mansoni: relationship between infection and anemia in Ugandan schoolchildren before and after praziquantel and albendazole chemotherapy,” American Journal of Tropical Medicine and Hygiene, vol. 75, no. 2, pp. 278–286, 2006. View at Google Scholar · View at Scopus
  57. Z. Mekonnen, S. Meka, A. Zeynudin, and S. Suleman, “Schistosoma mansoni infection and undernutrition among school age children in Fincha'a sugar estate, rural part of West Ethiopia,” BMC Research Notes, vol. 7, article 763, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. J. F. Friedman, H. K. Kanzaria, L. P. Acosta et al., “Relationship between Schistosoma Japonicum and nutritional status among children and young adults in Leyte, the Philippines,” American Journal of Tropical Medicine and Hygiene, vol. 72, no. 5, pp. 527–533, 2005. View at Google Scholar · View at Scopus
  59. G. F. Chami, A. Fenwick, E. Bulte, A. A. Kontoleon, N. B. Kabatereine et al., “Influence of Schistosoma mansoni and hookworm infection intensities on anaemia in Ugandan villages,” PLoS Neglected Tropical Diseases, vol. 9, article e0004193, 2015. View at Google Scholar
  60. G. R. Olds, C. King, J. Hewlett et al., “Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths,” Journal of Infectious Diseases, vol. 179, no. 4, pp. 996–1003, 1999. View at Publisher · View at Google Scholar · View at Scopus
  61. S. T. McGarvey, G. Aligui, K. K. Graham, P. Peters, G. Richard Olds, and R. Olveda, “Schistosomiasis japonica and childhood nutritional status in northeastern Leyte, the Philippines: a randomized trial of praziquantel versus placebo,” American Journal of Tropical Medicine and Hygiene, vol. 54, no. 5, pp. 498–502, 1996. View at Publisher · View at Google Scholar · View at Scopus
  62. C. H. King, R. F. Sturrock, H. C. Kariuki, and J. Hamburger, “Transmission control for schistosomiasis—why it matters now,” Trends in Parasitology, vol. 22, no. 12, pp. 575–582, 2006. View at Publisher · View at Google Scholar · View at Scopus